September 2023 – BASF agreed with Qore LLC to obtain a long-term supply of QIRA bio-based 1,4-butanediol (BDO), which will be produced at Cargill's Iowa biotech campus. BASF will expand its existing line of BDO derivatives with bio-based PolyTHF and THF variants. The first commercial ...
Singapore (GLOBE NEWSWIRE) - Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. CBR was founded in 20...
The only company from Asia to feature on the prestigious US-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list
The Boston-based company launched at the beginning of the year with a $110 million Series A round and scored collaboration deals with Genentech and Biogen to address diseases related to the central nervous system. 6. Dyno Therapeutics Dyno Therapeutics came roaring onto the biotech scene with ...
CELLINK By the Numbers Countries 0+ Publications 0+ Instruments 0+ Trusted by Industry Leaders Used by the leading companies, institutes and universities across a variety of sectors all over the globe. Explore our Customer Stories →
Chief Executive Severin Schwan said he believed there was a good strategic fit between Roche and the California-based biotech firm, and that it would continue to pursue “targeted” bolt-on acquisitions. Roche generates a large amount of cash, leading to persistent speculation about deals. Its ...
according to OpenSecrets. As scrutiny intensifies around prescription drug management and regulatory issues, spending is expected to soar even higher in the coming months. With the spotlight on biosafety legislation, biotech and pharmaceutical companies are poised to escalate their lobbying efforts further...
Whitfield, Mark
Recognized for accelerating promising medicines from early development through regulatory approval and market access, our custom-tailored solutions service pharma, biotech, medical device and government organizations. Learn moreOrdering Order Status Order Help Quick Order Supply Center eProcurement Support ...
Sino Biological has concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. ("SignalChem” or “SCB”). Sino Biological has acquired 100% of SignalChem shares in a deal valued at $48M USD. SignalChem is renowned for its specialized active enzymes, including...